Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AzaSite in chronic blepharitis
NCT00629941Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AzaSite in blepharitis, sponsored by Merck & Co.. Started Mar 2008; status: completed.
02
Drugs
AzaSite
03
Conditions
blepharitis
Beyond the preview
Go deeper on NCT00629941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00629941.